InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Heyman Tomas J., Director. Insider active across 2 companies, notably Akero Therapeutics, Inc.. Cumulatively, 8 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €178k. History available since 31 May 2023. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Heyman Tomas J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
8,367 shares0Common StockSEC:0000939767-26-000082:0
9,398 sharesCommon StockSEC:0001193125-25-312134:0
9,398 shares0Common StockSEC:0000950170-25-082307:0
9,812 shares0Common StockSEC:0000939767-25-000092:0
4,544 shares@ US$44.29100.0% of flowCommon StockSEC:0000939767-25-000084:0
18,838 shares0Common StockSEC:0000939767-24-000099:0
26,000 shares@ US$25.04100.0% of flowCommon StockSEC:0000950170-23-029231:0
18,176 shares0Common StockSEC:0000939767-23-000065:0
8 of 8 declarations
About Heyman Tomas J.
Tomas J. Heyman is a Director at Akero Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His expertise in the biopharmaceutical sector is essential for guiding Akero towards innovation and growth.
